Cargando…
The Impact of the CX3CL1/CX3CR1 Axis in Neurological Disorders
Fractalkine (FKN, CX3CL1) is a transmembrane chemokine expressed by neurons in the central nervous system (CNS). CX3CL1 signals through its unique receptor, CX3CR1, that is expressed in microglia. Within the CNS, fractalkine acts as a regulator of microglia activation in response to brain injury or...
Autores principales: | Pawelec, Paulina, Ziemka-Nalecz, Malgorzata, Sypecka, Joanna, Zalewska, Teresa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7600611/ https://www.ncbi.nlm.nih.gov/pubmed/33065974 http://dx.doi.org/10.3390/cells9102277 |
Ejemplares similares
-
Aberrant Complement System Activation in Neurological Disorders
por: Ziabska, Karolina, et al.
Publicado: (2021) -
Role of CX3CL1/CX3CR1 Signaling Axis Activity in Osteoporosis
por: Wojdasiewicz, Piotr, et al.
Publicado: (2019) -
Analysis of Givinostat/ITF2357 Treatment in a Rat Model of Neonatal Hypoxic-Ischemic Brain Damage
por: Pawelec, Paulina, et al.
Publicado: (2022) -
CX3CL1/CX3CR1 Axis, as the Therapeutic Potential in Renal Diseases: Friend or Foe?
por: Zhuang, Quan, et al.
Publicado: (2017) -
CX3CL1–CX3CR1 Axis: A New Player in Coeliac Disease Pathogenesis
por: Fernández-Prieto, Marta, et al.
Publicado: (2019)